Abstract
Hemeproteins are essential for life and heme insertion is an essential step in their maturation. Maturation of hemeprotein requires that they incorporate heme and become active, but knowledge of this essential cellular process remains incomplete. However recent studies on chaperon Hsp90 has revealed that it drives functional heme insertion in vital hemeproteins like inducible nitric oxide synthase (iNOS), soluble guanylate cyclase (sGC) and hemoglobin (Hb). In all three cases Hsp90 interacts with the heme-free or apo-protein and then drives the heme insertion by an ATP dependent process before dissociating from the heme-replete proteins. Given the diverse role of chaperon Hsp90, and in particular to it being a major therapeutic target in drug discovery programs these findings add up to Hsp90’s repertoire of being a druggable target and opens up more avenues in regulating growth of diseased cells in those pathologic conditions where these hemeproteins are dysfunctional.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AHSP:
-
Alpha hemoglobin stabilizing protein
- AIF:
-
Apoptosis-inducing factor
- Apaf-1:
-
Apoptotic protease activating factor 1
- Ask-1:
-
Apoptosis signal-regulating kinase 1
- ATP:
-
Adenosine triphosphate
- cGMP:
-
Cyclic guanosine monophosphate
- ECM:
-
Extracellular matrix
- FLVCRb:
-
Feline leukemia virus subgroup c receptor b
- Hb:
-
Hemoglobin
- HDM:
-
House dust mite
- Her-2:
-
Human epidermal growth factor receptor 2
- Hip:
-
hsp70-interacting protein
- H-NOX:
-
Heme nitric oxide/oxygen
- Hop:
-
hsp70/hsp90 organizing protein
- Hsp90:
-
Heat shock protein 90
- iNOS:
-
Inducible nitric oxide synthase
- IPF:
-
Idiopathic pulmonary fibrosis
- MMPs:
-
Matrix metalloproteinases
- NO:
-
Nitric oxide
- NOS:
-
Nitric oxide synthase
- NOX:
-
NADPH oxidase
- per2:
-
Period circadian regulator 2
- ROS:
-
Reactive oxygen species
- sGC:
-
Soluble guanylate cyclase
- TGF-β1:
-
Transforming growth factor-β1
- VEGF:
-
Vascular endothelial growth factor
References
Aguilà M, Cheetham ME (2016) Hsp90 as a potential therapeutic target in retinal disease. Adv Exp Med Biol 854:161–167
Ali MM, Roe SM, Vaughan CK et al (2006) Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex. Nature 440:1013–1017
Billecke SS, Draganov DI, Morishima Y et al (2004) The role of hsp90 in heme-dependent activation of apo-neuronal nitric-oxide synthase. J Biol Chem 279:30252–30258
Bonniaud P, Bellaye PS, Burgy O, Kolb M (2017) Heat shock protein: a hot topic in idiopathic pulmonary fibrosis. Eur Respir J 49:1602152
Bryan NS, Bian K, Murad F (2009) Discovery of the nitric oxide signaling pathway and targets for drug development. Front Biosci 14:1–18
Byon JC, Chen J, Doty RT, Abkowitz JL (2013) FLVCR is necessary for erythroid maturation, may contribute to platelet maturation, but is dispensable for normal hematopoietic stem cell function. Blood 122:2903–2910
Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases—the role of oxidant stress. Circ Res 87:840–844
Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR (2006) Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31:164–172
Chen B, Piel WH, Gui L, Bruford E, Monteiro A (2005) The HSP90 family of genes in the human genome: insights into their divergence and evolution. Genomics 86:627–637
Chen Z et al (2010) Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogene. Cancer Res 70:9827–9836
Chen F, Pandey D, Chadli A, Catravas JD, Chen T, Fulton DJ (2011) Hsp90 regulates NADPH oxidase activity and is necessary for superoxide but not hydrogen peroxide production. Antioxid Redox Signal 14:2107–2119
Chiosis G, Tao H (2006) Purine-scaffold Hsp90 inhibitors. IDrugs 9:778–782
Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86–103
Correia AL, Mori H, Chen EI, Schmitt FC, Bissell MJ (2013) The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90beta. Genes Dev 27:805–817
Crane BR, Arvai AS, Ghosh DK et al (1998) Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 279:2121–2126
Csermely P, Schnaider T, Soti C, Prohaszka Z, Nardai G (1998) The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol Ther 79:129–168
Dimitropoulou C, Snead C, Gallops J, Catravas JD (2010) Heat shock protein 90 inhibitors reduce airway inflammation in a mouse model of allergic asthma. FASEB J 24(Suppl 1)
Do K, Speranza G, Chang LC et al (2015) Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors. Investig New Drugs 33:921–930
Dong HM, Le YQ, Wang YH et al (2017) Extracellular heat shock protein 90α mediates HDM-induced bronchial epithelial barrier dysfunction by activating RhoA/MLC signaling. Respir Res 18:111
Dumont ME, Cardillo TS, Hayes MK, Sherman F (1991) Role of cytochrome c heme lyase in mitochondrial import and accumulation of cytochrome c in Saccharomyces cerevisiae. Mol Cell Biol 11:5487–5496
Eccles SA, Massey A, Raynaud FI et al (2008) NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis. Cancer Res. 2008 68:2850–2860
Elpek GO, Karaveli S, Simsek T, Keles N, Aksoy NH (2003) Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries. APMIS 111:523–530
Fadden P, Huang KH, Veal JM et al (2010) Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90. Chem Biol 17:686–694
Faou P, Hoogenraad NJ (2012) Tom34: a cytosolic cochaperone of the Hsp90/Hsp70 protein complex involved in mitochondrial protein import. Biochim Biophys Acta 1823:348–357
Feng L, Zhou S, Gu L et al (2005) Structure of oxidized alpha-haemoglobin bound to AHSP reveals a protective mechanism for haem. Nature 435:697–701
Fleming MD, Hamza I (2012) Mitochondrial heme: an exit strategy at last. J Clin Invest 122:4328–4330
Froese AR, Shimbori C, Bellaye PS et al (2016) Stretch-induced activation of transforming growth factor-β1 in pulmonary fibrosis. Am J Respir Crit Care Med 194:84–96
Fuhrmann-Stroissnigg H, Ling YY, Zhao J et al (2017) Identification of HSP90 inhibitors as a novel class of senolytics. Nat Commun 8:422
Fulda S, Galluzzi L, Kroemer G (2010) Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9:447–464
Ghosh S, Erzurum SC (2011) Nitric oxide metabolism in asthma pathophysiology. Biochim Biophys Acta 1810:1008–1016
Ghosh A, Stuehr DJ (2012) Soluble guanylyl cyclase requires heat shock protein 90 for heme insertion during maturation of the NO-active enzyme. Proc Natl Acad Sci U S A 109:12998–13003
Ghosh A, Chawla-Sarkar M, Stuehr DJ (2011) Hsp90 interacts with inducible NO synthase client protein in its heme-free state and then drives heme insertion by an ATP-dependent process. FASEB J 25:2049–2060
Ghosh A, Stasch JP, Papapetropoulos A, Stuehr DJ (2014) Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content. J Biol Chem 289:15259–15271
Ghosh A, Koziol-White CJ, Asosingh K et al (2016) Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma. Proc Natl Acad Sci U S A 113:E2355–E2362
Ghosh A, Garee G, Sweeny EA, Nakamura Y, Stuehr DJ (2018) Hsp90 chaperones hemoglobin maturation in erythroid and non-erythroid cells. Proc Natl Acad Sci U S A 115:E1117–E1126
Gomez-Monterrey I, Sala M, Musella S, Campiglia P (2012) Heat shock protein 90 inhibitors as therapeutic agents. Recent Pat Anticancer Drug Discov 7:313–336
Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494–501
Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC (1995) Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A 92:7809–7813
Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364
Hopkins RB, Burke N, Fell C, Dion G, Kolb M (2016) Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada. Eur Respir J 48:187–195
Ignarro LJ, Adams JB, Horwitz PM, Wood KS (1986) Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms. J Biol Chem 261:4997–5002
Intapad S, Dimitropoulou C, Snead C, Piyachaturawat P, Catravas JD (2012) Regulation of asthmatic airway relaxation by estrogen and heat shock protein 90. J Cell Physiol 227:3036–3043
Iwasaki M, Saito H, Yamamoto M, Korach KS, Hirogome T, Sugano H (1989) Purification of heat shock protein 90 from calf uterus and rat liver and characterization of the highly hydrophobic region. Biochim Biophys Acta 992:1–8
Jackson SE, Queitsch C, Toft D (2004) Hsp90: from structure to phenotype. Nat Struct Mol Biol 11:1152–1155
Kamal A, Thao L, Sensintaffar J et al (2003) A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425:407–410
Kihm AJ, Kong Y, Hong W et al (2002) An abundant erythroid protein that stabilizes free alpha-haemoglobin. Nature 417:758–763
Kim YS (2009) Update on Hsp90 inhibitors in clinical trial. Curr Top Med Chem 9:1479–1492
Krukenberg KA, Street TO, Lavery LA, Agard DA (2011) Conformational dynamics of the molecular chaperone Hsp90. Q Rev Biophys 44:229–255
Lagarrigue F, Dupuis-Coronas S, Ramel D et al (2010) Matrix metalloproteinase-9 is upregulated in nucleophosmin-anaplastic lymphoma kinase-positive anaplastic lymphomas and activated at the cell surface by the chaperone heat shock protein 90 to promote cell invasion. Cancer Res 70:6978–6987
Lazarow PB, de Duve C (1973) The synthesis and turnover of rat liver peroxisomes. V. Intracellular pathway of catalase synthesis. J Cell Biol 59:507–524
Lebret T, Watson RW, Molinié V et al (2003) Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma. Cancer 98:970–977
Li J, Buchner J (2013) Structure, function and regulation of the hsp90 machinery. Biom J 36:106–117
Liu X, Yu Y, Hu C, Zhang W, Lu Y, Wang J (2012) Significant increase of oxidase activity through the genetic incorporation of a tyrosine-histidine cross-link in a myoglobin model of heme-copper oxidase. Angew Chem Int Ed Eng 51:4312–4316
Lu Y, Yeung N, Sieracki N, Marshall NM (2009) Design of functional metalloproteins. Nature 460:855–862
Luo W, Sun W, Taldone T, Rodina A, Chiosis G (2010) Heat shock protein 90 in neurodegenerative diseases. Mol Neurodegener 5:24
Makhnevych T, Houry WA (2012) The role of Hsp90 in protein complex assembly. Biochim Biophys Acta 1823:674–682
Martin F, Baskaran P, Ma X et al (2010) Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase. J Biol Chem 285:22651–22657
McCarthy MM, Pick E, Kluger Y et al (2008) HSP90 as a marker of progression in melanoma. Ann Oncol 19:590–594
McClellan AJ, Xia Y, Deutschbauer AM, Davis RW, Gerstein M, Frydman J (2007) Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches. Cell 131:121–135
Miyata Y, Nakamoto H, Neckers L (2013) The therapeutic target Hsp90 and cancer hallmarks. Curr Pharm Des 19:347–365
Modi S, Stopeck A, Linden H et al (2011) HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab. Clin Cancer Res 17:5132–5139
Mora AL, Rojas M, Pardo A, Selman M (2017) Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease. Nat Rev Drug Discov 16:755–772
Murad F (2006) Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med 355:2003–2011
Nauseef WM, McCormick S, Yi H (1992) Roles of heme insertion and the mannose-6-phosphate receptor in processing of the human myeloid lysosomal enzyme, myeloperoxidase. Blood 80:2622–2633
Neckers L (2002) Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med 8:S55–S61
Neckers L, Workman P (2012) Hsp90 molecular chaperone inhibitors: are we there yet? Clin Cancer Res 18:64–76
Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18:1135–1149
Nimmanapalli R, O’Bryan E, Bhalla K (2001) Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts. Cancer Res 61:1799–1804
Overgaard D, Kaldan G, Marsaa K, Nielsen TL, Shaker SB, Egerod I (2016) The lived experience with idiopathic pulmonary fibrosis: a qualitative study. Eur Respir J 47:1472–1480
Pandey P, Saleh A, Nakazawa A et al (2000) Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J 19:4310–4322
Pankey EA, Bhartiya M, Badejo AM Jr (2011) Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme. Am J Physiol Heart Circ Physiol 300:H792–H802
Paoli M, Marles-Wright J, Smith A (2002) Structure-function relationships in heme-proteins. DNA Cell Biol. 2002 21:271–280
Park SJ, Kostic M, Dyson HJ (2011) Dynamic interaction of Hsp90 with its client protein p53. J Mol Biol 411:158–173
Pezzulo A, Tudas RA, Stewart CG et al (2018) HSP90 inhibition reverts IL13- and IL17-induced goblet cell metaplasia in human airway epithelia. Am J Respir Crit Care Med 197:A1296
Pillai RN, Ramalingam SS (2012) Hsp90 inhibitors. J Thorac Oncol 7:S407–S408
Pockley AG, Multhoff G (2008) Cell stress proteins in extracellular fluids: friend or foe? Novartis Found Symp 291:86–95
Pockley AG, Muthana M, Calderwood SK (2008) The dual immunoregulatory roles of stress proteins. Trends Biochem Sci 33:71–79
Ponka P (1999) Cell biology of heme. Am J Med Sci 318:241–256
Poulos TL (2014) Heme enzyme structure and function. Chem Rev 114:3919–3962
Prodromou C (2012) The ‘active life’ of Hsp90 complexes. Biochim Biophys Acta 1823:614–623
Ratajczak T, Ward BK, Walsh JP, Cluning C (2015) Hsp90 as a therapeutic target in endocrinology: current evidence. Res Rep Endocr Disord 5:141–155
Ratzke C, Berkemeier F, Hugel T (2012) Heat shock protein 90’s mechanochemical cycle is dominated by thermal fluctuations. Proc Natl Acad Sci U S A 109:161–166
Richard-Fogal CL, Frawley ER, Bonner ER, Zhu H, San Francisco B, Kranz RG (2009) A conserved haem redox and trafficking pathway for cofactor attachment. EMBO J 28:2349–2359
Sandner P, Berger P, Zenzmaier C (2017) The potential of sGC modulators for the treatment of age-related fibrosis: a mini-review. Gerontology 63:216–227
Severance S, Hamza I (2009) Trafficking of heme and porphyrins in metazoa. Chem Rev 109:4596–4616
Shimamura T, Shapiro GI (2008) Heat shock protein 90 inhibition in lung cancer. J Thorac Oncol 3:S152–S159
Sibinska Z, Tian X, Korfei M et al (2017) Amplified canonical transforming growth factor-β signalling via heat shock protein 90 in pulmonary fibrosis. Eur Respir J 49:1501941
Sims JD, McCready J, Jay DG (2011) Extracellular heat shock protein (Hsp)70 and Hsp90α assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion. PLoS One 6:e18848
Smith AT, Veitch NC (1998) Substrate binding and catalysis in heme peroxidases. Curr Opin Chem Biol 2:269–278
Socinski MA, Goldman J, El-Hariry I et al (2013) A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer. Clin Cancer Res 19:3068–3077
Song X, Wang X, Zhuo W et al (2010) The regulatory mechanism of extracellular Hsp90{alpha} on matrix metalloproteinase-2 processing and tumor angiogenesis. J Biol Chem 285:40039–40049
Sontake V, Wang Y, Kasam RK et al (2017) Hsp90 regulation of fibroblast activation in pulmonary fibrosis. JCI Insight 2:e91454
Southworth DR, Agard DA (2011) Client-loading conformation of the Hsp90 molecular chaperone revealed in the cryo-EM structure of the human Hsp90: Hop complex. Mol Cell 42:771–781
Spiro TG, Soldatova AV, Balakrishnan G (2013) CO, NO and O2 as vibrational probes of heme protein interactions. Coord Chem Rev 257:511–527
Stasch JP, Pacher P, Evgenov OV (2011) Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. Circulation 123:2263–2273
Steiner H, Kispal G, Zollner A, Haid A, Neupert W, Lill R (1996) Heme binding to a conserved Cys-Pro-Val motif is crucial for the catalytic function of mitochondrial heme lyases. J Biol Chem 271:32605–32611
Taipale M, Jarosz DF, Lindquist S (2010) HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 11:515–528
Taketani S (2005) Aquisition, mobilization and utilization of cellular iron and heme: endless findings and growing evidence of tight regulation. Tohoku J Exp Med 205:297–318
Taldone T, Ochiana SO, Patel PD, Chiosis G (2014) Selective targeting of the stress chaperome as a therapeutic strategy. Trends Pharmacol Sci 35:592–603
Taylor BL, Zhulin IB (1999) PAS domains: internal sensors of oxygen, redox potential, and light. Microbiol Mol Biol Rev 63:479–506
Tóth ME, Gombos I, Sántha M (2015) Heat shock proteins and their role in human diseases. Acta Biol Szeged 59:121–141
Trepel J, Mollapour M, Giaccone G, Neckers L (2010) Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10:537–549
Tsiftsoglou AS, Tsamadou AI, Papadopoulou LC (2006) Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. Pharmacol Ther 111:327–345
Verbeke P, Fonager J, Clark BF, Rattan SI (2001) Heat shock response and ageing: mechanisms and applications. Cell Biol Int 25:845–857
Wang X, Dumont ME, Sherman F (1996) Sequence requirements for mitochondrial import of yeast cytochrome c. J Biol Chem 271:6594–6604
Wang X, Song X, Zhuo W et al (2009) The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy. Proc Natl Acad Sci U S A 106:21288–21293
Weiss MJ, dos Santos CO (2009) Chaperoning erythropoiesis. Blood 113:2136–2144
West AR, Oates PS (2008) Mechanisms of heme iron absorption: current questions and controversies. World J Gastroenterol 14:4101–4110
Whitesell L, Lindquist SL (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761–772
Wijayanti N, Katz N, Immenschuh S (2004) Biology of heme in health and disease. Curr Med Chem 11:981–986
Xu W, Neckers L (2007) Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells. Clin Cancer Res 13:1625–1629
Yamakura F, Ikeda K (2006) Modification of tryptophan and tryptophan residues in proteins by reactive nitrogen species. Nitric Oxide 14:152–161
Yamamoto M, Takahashi Y, Inano K, Horigome T, Sugano H (1991) Characterization of the hydrophobic region of heat shock protein 90. J Biochem 110:141–145
Yi L, Jenkins PM, Leichert LI, Jakob U, Martens JR, Ragsdale SW (2009) Heme regulatory motifs in heme oxygenase-2 form a thiol/disulfide redox switch that responds to the cellular redox state. J Biol Chem 284:20556–20561
Yoshikawa S, Shinzawa-Itoh K, Nakashima R et al (1998) Redox-coupled crystal structural changes in bovine heart cytochrome c oxidase. Science 280:1723–1729
Yu X, Kong Y, Dore LC et al (2007) An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis. J Clin Invest 117:1856–1865
Zhang R, Luo D, Miao R et al (2005) Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis. Oncogene 24:3954–3963
Acknowledgements
This work is supported by National Institute of Health Grant HL081064 (to D.J.S and A.G.) and a Research Centre for Excellence Grant from the Cleveland Clinic (to A.G. and D.J.S.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ghosh, A., Stuehr, D.J. (2019). Hsp90 and Its Role in Heme-Maturation of Client Proteins: Implications for Human Diseases. In: Asea, A., Kaur, P. (eds) Heat Shock Protein 90 in Human Diseases and Disorders. Heat Shock Proteins, vol 19. Springer, Cham. https://doi.org/10.1007/978-3-030-23158-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-23158-3_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23157-6
Online ISBN: 978-3-030-23158-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)